Evolving Models of HIV Care (Volume 3)The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Carvalhal A. Health Care: Current Reviews. 2015;3(1).
Coffey S, Bacon O. HIV InSite. Updated May 2020.
Coffey S, et al. Clin Infect Dis. 2020 (Epub ahead of print).
Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.
Colasanti J, et al. Open Forum Infect Dis. 2018;5(6):ofy104.
Eisinger RW, et al. JAMA. 2019;321(5):451-452.
Pathways to health: an examination of HIV-related stigma, life stressors, depression, and substance use.
Glynn TR, et al. Int J Behav Med. 2019;26(3):286-296.
Depression prevalence, antidepressant treatment status, and association with sustained HIV viral suppression among adults living with HIV in care in the United States, 2009–2014.
Gokhale RH, et al. AIDS Behav. 2019;23(12):3452-3459.
A care continuum of immediate ART for newly diagnosed patients and patients presenting later to care at a Federally Qualified Health Center in New Orleans.
Halperin J, et al. Open Forum Infect Dis. 2019;6(4):ofz161.
Smith DK, et al. Open Forum Infect Dis. 2018;5(8):ofy180.
Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.
Stone. VE. Curr HIV/AIDS Rep. 2005;2(4):189-193.
Rapid ART Initiation: A Key Strategy for Ending the HIV Epidemic
Overcoming Barriers: Successful Rapid ART Initiation
Evolving Models of HIV Care (Volume 3)
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
Key Issues Impacting OB/GYN Practice
Hot Topics in HBV, HCV, and NASH
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
An Updated Clinician’s Guide to Assessment and Management
What the Pharmacist Needs to Know
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
A Phone-a-Friend CME Series – Volume 2
Incorporating New Data and Updated Guidelines Into Daily Practice